Showing results (51-60 of 5,277) with videos related to

Sort By:
Pageof 528
Current Medicinal Chemistry|February 21, 2023
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal CandidiasisSurya K De
Anti-Cancer Agents in Medicinal Chemistry|March 24, 2023
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with MyelofibrosisSurya K De
Recent Patents on Anti-Cancer Drug Discovery|February 28, 2023
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other DiseasesSurya K De
Social Science & Medicine (1982)|January 1, 1988
Mortality in children among the Aymara Indians of southern PeruK de Meer
Anti-Cancer Agents in Medicinal Chemistry|December 5, 2024
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast CancerSurya K De
Current Medicinal Chemistry|July 26, 2023
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other DiseasesSurya K De
International Journal of Health Economics and Management|May 2, 2021
Impacts of insurance expansion on health cost, health access, and health behaviors: evidence from the medicaid expansion in the USPrabal K De
Recent Patents on Anti-Cancer Drug Discovery|December 8, 2022
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other DiseasesSurya K De
Phonetica|January 1, 1991
An articulatory study of consonant-induced vowel duration changes in EnglishK de Jong
Current Medicinal Chemistry|June 1, 2023
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating DiseasesSurya K De
Pageof 528